Dengue vaccine: hypotheses to understand CYD-TDV-induced protection
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dengue vaccine: hypotheses to understand CYD-TDV-induced protection
Authors
Keywords
-
Journal
NATURE REVIEWS MICROBIOLOGY
Volume 14, Issue 1, Pages 45-54
Publisher
Springer Nature
Online
2015-12-07
DOI
10.1038/nrmicro.2015.2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An Adjuvanted, Tetravalent Dengue Virus Purified Inactivated Vaccine Candidate Induces Long-Lasting and Protective Antibody Responses Against Dengue Challenge in Rhesus Macaques
- (2015) Stefan Fernandez et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- CD8+T Cells Can Mediate Short-Term Protection against Heterotypic Dengue Virus Reinfection in Mice
- (2015) Raphaël M. Zellweger et al. JOURNAL OF VIROLOGY
- Dengue
- (2015) Maria G Guzman et al. LANCET
- Preventing Dengue — Is the Possibility Now a Reality?
- (2015) Stephen J. Thomas NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
- (2015) Sri Rezeki Hadinegoro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
- (2015) Luis Villar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Virus-specific T lymphocytes home to the skin during natural dengue infection
- (2015) Laura Rivino et al. Science Translational Medicine
- Research on Dengue During World War II Revisited
- (2014) Grace E. Snow et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- CD8+T Cells Prevent Antigen-Induced Antibody-Dependent Enhancement of Dengue Disease in Mice
- (2014) Raphaël M. Zellweger et al. JOURNAL OF IMMUNOLOGY
- Preexisting Neutralizing Antibody Responses Distinguish Clinically Inapparent and Apparent Dengue Virus Infections in a Sri Lankan Pediatric Cohort
- (2014) Kizzmekia S. Corbett et al. JOURNAL OF INFECTIOUS DISEASES
- Isolation of Dengue Virus-Specific Memory B Cells with Live Virus Antigen from Human Subjects following Natural Infection Reveals the Presence of Diverse Novel Functional Groups of Antibody Clones
- (2014) S. A. Smith et al. JOURNAL OF VIROLOGY
- Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
- (2014) Maria Rosario Capeding et al. LANCET
- A neighborhood watch upholds local immune protection
- (2014) F. R. Carbone et al. SCIENCE
- Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naïve adults in Mexico
- (2014) Gustavo H Dayan et al. Human Vaccines & Immunotherapeutics
- Dengue Virus Neutralizing Antibody Levels Associated with Protection from Infection in Thai Cluster Studies
- (2014) Darunee Buddhari et al. PLoS Neglected Tropical Diseases
- Epidemiological Risk Factors Associated with High Global Frequency of Inapparent Dengue Virus Infections
- (2014) Laura Grange et al. Frontiers in Immunology
- A Shorter Time Interval Between First and Second Dengue Infections Is Associated With Protection From Clinical Illness in a School-based Cohort in Thailand
- (2013) Kathryn B. Anderson et al. JOURNAL OF INFECTIOUS DISEASES
- Reduced Risk of Disease During Postsecondary Dengue Virus Infections
- (2013) Sandra Olkowski et al. JOURNAL OF INFECTIOUS DISEASES
- Innate Immunity to Dengue Virus Infection and Subversion of Antiviral Responses
- (2013) Angela M. Green et al. JOURNAL OF MOLECULAR BIOLOGY
- Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity
- (2013) N. G. Reich et al. Journal of the Royal Society Interface
- High-Avidity and Potently Neutralizing Cross-Reactive Human Monoclonal Antibodies Derived from Secondary Dengue Virus Infection
- (2013) Wen-Yang Tsai et al. JOURNAL OF VIROLOGY
- The global distribution and burden of dengue
- (2013) Samir Bhatt et al. NATURE
- Safety and Immunogenicity of a Recombinant Tetravalent Dengue Vaccine in 9–16 Year Olds
- (2013) Luis Á. Villar et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Genetic Variants of MICB and PLCE1 and Associations with Non-Severe Dengue
- (2013) James Whitehorn et al. PLoS One
- Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells
- (2013) D. Weiskopf et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Potent and Broadly Neutralizing Human Dengue Virus-Specific Monoclonal Antibody 1C19 Reveals a Unique Cross-Reactive Epitope on the bc Loop of Domain II of the Envelope Protein
- (2013) S. A. Smith et al. mBio
- Persistence of Th1/Tc1 responses one year after tetravalent dengue vaccination in adults and adolescents in Singapore
- (2013) Anke Harenberg et al. Human Vaccines & Immunotherapeutics
- Symptomatic Versus Inapparent Outcome in Repeat Dengue Virus Infections Is Influenced by the Time Interval between Infections and Study Year
- (2013) Magelda Montoya et al. PLoS Neglected Tropical Diseases
- Analysis of Cross-Reactive Antibodies Recognizing the Fusion Loop of Envelope Protein and Correlation with Neutralizing Antibody Titers in Nicaraguan Dengue Cases
- (2013) Chih-Yun Lai et al. PLoS Neglected Tropical Diseases
- Role of Humoral versus Cellular Responses Induced by a Protective Dengue Vaccine Candidate
- (2013) Raphaël M. Zellweger et al. PLoS Pathogens
- Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
- (2012) Arunee Sabchareon et al. LANCET
- Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions
- (2012) R. de Alwis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dominant Cross-Reactive B Cell Response during Secondary Acute Dengue Virus Infection in Humans
- (2012) Simona Zompi et al. PLoS Neglected Tropical Diseases
- Priming Effect of Dengue and Yellow Fever Vaccination on the Immunogenicity, Infectivity, and Safety of a Tetravalent Dengue Vaccine in Humans
- (2011) Ming Qiao et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Immune Response to Dengue Virus and Prospects for a Vaccine
- (2011) Brian R. Murphy et al. Annual Review of Immunology
- Protection from Secondary Dengue Virus Infection in a Mouse Model Reveals the Role of Serotype Cross-Reactive B and T Cells
- (2011) S. Zompi et al. JOURNAL OF IMMUNOLOGY
- B-Cell Responses During Primary and Secondary Dengue Virus Infections in Humans
- (2011) Anuja Mathew et al. JOURNAL OF INFECTIOUS DISEASES
- Dynamics of Dengue Disease Severity Determined by the Interplay Between Viral Genetics and Serotype-Specific Immunity
- (2011) M. OhAinle et al. Science Translational Medicine
- Introduction
- (2011) Beth-Ann Coller et al. VACCINE
- Development of DENVax: A chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever
- (2011) Jorge E. Osorio et al. VACCINE
- Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: Randomized controlled phase I trial in the Philippines
- (2011) Rosario Z. Capeding et al. VACCINE
- Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccine
- (2011) Anna P. Durbin et al. VACCINE
- From research to phase III: Preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine
- (2011) Bruno Guy et al. VACCINE
- Determinants of Inapparent and Symptomatic Dengue Infection in a Prospective Study of Primary School Children in Kamphaeng Phet, Thailand
- (2011) Timothy P. Endy et al. PLoS Neglected Tropical Diseases
- A Novel Tetravalent Dengue Vaccine Is Well Tolerated and Immunogenic against All 4 Serotypes inFlavivirus‐Naive Adults
- (2010) Dennis Morrison et al. JOURNAL OF INFECTIOUS DISEASES
- Different Innate Signatures Induced in Human Monocyte-derived Dendritic Cells by Wild-Type Dengue 3 Virus, Attenuated but Reactogenic Dengue 3 Vaccine Virus, or Attenuated Nonreactogenic Dengue 1-4 Vaccine Virus Strains
- (2010) C. Balas et al. JOURNAL OF INFECTIOUS DISEASES
- Dengue: a continuing global threat
- (2010) Maria G. Guzman et al. NATURE REVIEWS MICROBIOLOGY
- Live-attenuated Tetravalent Dengue Vaccine in Dengue-naïve Children, Adolescents, and Adults in Mexico City
- (2010) Jorge Poo et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Age‐Related Increase in the Frequency of CD4+T Cells That Produce Interferon‐γ in Response to Staphylococcal Enterotoxin B during Childhood
- (2009) Rima Hanna‐Wakim et al. JOURNAL OF INFECTIOUS DISEASES
- Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects
- (2008) Bruno Guy et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started